Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA approves Teva generic HIV treatment
Globes, Israel
Sunday, May 29, 2011 - 1:03pm
tags:
Teva Pharmaceuticals, Combivir, HIV
Lupin expects to launch 50 products globally in FY12
Economic Times, India
Sunday, May 29, 2011 - 1:01pm
tags:
Lupin
Sun Pharma Profit Beats Estimates on Israeli Unit’s Sales Gain
Bloomberg
Sunday, May 29, 2011 - 12:58pm
tags:
Sun Pharma, Taro
Rigel Refuels R&D in $130M Offering
Seeking Alpha
Sunday, May 29, 2011 - 12:47pm
tags:
Rigel, fostamatinib, rheumatoid arthritis, AstraZeneca, R343, asthma
Investment Focus : Divis Laboratories - Buy
Hindu Business Line, India
Saturday, May 28, 2011 - 2:07pm
tags:
Divi's Laboratories, outsourcing
US FDA approves trial of Pathway Therapeutics cancer drug
pharmabiz
Saturday, May 28, 2011 - 2:05pm
tags:
Pathway Therapeutics, PWT33597, mTOR inhibitors, PI3K, oncology, cancer
BeiGene And Merck & Co To Discover Cancer Medicines
Pharmceutical Insight
Saturday, May 28, 2011 - 2:03pm
tags:
BeiGene, Merck, cancer, oncology
MAP Pharmaceuticals looks to FDA for migraine treatment approval
Medreps
Saturday, May 28, 2011 - 2:02pm
tags:
MAP Pharmaceuticals, Levadex, migraines
House Energy, Commerce Panel Expands Heparin-Related Investigation
livemint
Saturday, May 28, 2011 - 1:57pm
tags:
Heparin
Mylan plans direct entry into India
livemint
Saturday, May 28, 2011 - 1:55pm
tags:
Mylan
AIM-HIGH? These Drugmakers Better Duck
Motley Fool
Saturday, May 28, 2011 - 12:18pm
tags:
AstraZeneca, Pfizer, Bristol-Myers Squibb, HDL therapy
Keller Rohrback L.L.P. Announces Investigation of Pfizer Smoking Cessation Drug Chantix
Yahoo/BusinessWire
Saturday, May 28, 2011 - 12:17pm
tags:
Pfizer, smoking cessation, Chantix
Watson Acquires Specifar
Yahoo/Zacks
Saturday, May 28, 2011 - 12:16pm
tags:
Watson Pharmaceuticals, Specifar
J&J shares climb after upbeat update on its drugs
Yahoo/AP
Saturday, May 28, 2011 - 12:15pm
tags:
JNJ
Analysts see lower sales for Abbott's Niaspan
Yahoo/AP
Saturday, May 28, 2011 - 12:14pm
tags:
Abbott Laboratories, Niaspan
Implications of the Niaspan Study on Abbott and Biosciences
Seeking Alpha
Saturday, May 28, 2011 - 12:13pm
tags:
Niaspan, Abbott Laboratories
Will Abbott Laboratories Disappoint Analysts Next Quarter?
Motley Fool
Saturday, May 28, 2011 - 12:11pm
tags:
Abbott Laboratories
Eli Lilly Dividend, Cash Flow Safe Despite Patent Cliff: Barclays
Barron's
Saturday, May 28, 2011 - 12:10pm
tags:
Eli Lilly
Johnson & Johnson Unveils Revitalized Pipeline
Seeking Alpha
Saturday, May 28, 2011 - 12:08pm
tags:
JNJ, pipelines
A Hidden Reason Why Eli Lilly's Earnings Are Outstanding
Motley Fool
Saturday, May 28, 2011 - 12:07pm
tags:
Eli Lilly, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.